Listeria Monocytogenes Meningoencephalitis Due to IRAK4 Deficiency

J Clin Immunol. 2021 Oct;41(7):1677-1680. doi: 10.1007/s10875-021-01074-8. Epub 2021 Jul 7.

Authors

Ding Liu^#¹, Ru Chen^#¹, Longfeng Ran¹, Ruxu Zhang², Han Chen³

Affiliations

¹ Department of Neurology, Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China.
² Department of Neurology, Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China. zhangruxu@vip.163.com.
³ Department of Neurology, Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China. han.chen@csu.edu.cn.

^# Contributed equally.

PMID: 34232442
DOI: 10.1007/s10875-021-01074-8

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Anti-Bacterial Agents / therapeutic use
Female
Humans
Immunoglobulins, Intravenous / therapeutic use
Interleukin-1 Receptor-Associated Kinases / deficiency
Interleukin-1 Receptor-Associated Kinases / genetics*
Listeria monocytogenes / genetics
Listeriosis / drug therapy
Listeriosis / genetics*
Meningoencephalitis / drug therapy
Meningoencephalitis / genetics*
Mutation
Primary Immunodeficiency Diseases / drug therapy
Primary Immunodeficiency Diseases / genetics*

Substances

Anti-Bacterial Agents
Immunoglobulins, Intravenous
IRAK4 protein, human
Interleukin-1 Receptor-Associated Kinases